MedTrace Logo

Westlake Precision Birth Cohort

NCT04060056 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2001

Last updated 2025-04-03

No results posted yet for this study

Summary

The Westlake Precision Birth Cohort (WeBirth) is a prospective cohort study among women with hyperglycemia during pregnancy and their offspring living in Hangzhou, China. The primary aim of this cohort is to characterize the continuous blood glucose response to dietary intake and physical activity among pregnant women with gestational diabetes mellitus (GDM) over 2 weeks, and to facilitate the development of personalized nutritional/lifestyle recommendation among these patients. Another aim of WeBirth is to investigate the association of dietary intake and physical activity together with continuous glucose change during pregnancy on the adverse birth outcomes including preterm birth, macrosomia and large-for-gestational-age birth. The secondary aim is to investigate the prospective associations of diet, physical activity and continuous glucose change over 2 weeks among the participants with long-term metabolic health of these women and their offspring.

Conditions

  • Diabetes, Gestational
  • Pregnancy in Diabetics
  • Intrauterine Hyperglycemia

Interventions

OTHER

Standardized breakfast

Participants will be provided with a standardized breakfast on a morning of the days they wear a continuous glucose monitoring (CGM) device.

OTHER

Standardized snack

Participants will be provided with a standardized snack 2 hour after they have the standardized breakfast.

OTHER

Standardized lunch

Participants will be provided with a standardized lunch 2 h after they have the standardized snack.

Sponsors & Collaborators

  • Hangzhou Maternal and Child Health Hospital

    collaborator UNKNOWN

  • Westlake University

    lead OTHER

Principal Investigators

  • Ju-Sheng Zheng, PhD · Westlake University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-30
Primary Completion
2025-11-30
Completion
2029-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04060056 on ClinicalTrials.gov